Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs intravenous iron for iron deficiency anemia after acute gastrointestinal bleeding
2016-002660-13Phase 4Active
- Sponsor
- Hospital General Universitario de Valencia
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in iron deficiency anemia (IDA) comparing Intravenous ferric carboxymaltose with Oral iron sulfate (2 arms). Primary endpoint: Evolution of hemoglobin levels. Started Sep 2016; status: active.
02
Drugs
ferric carboxymaltoseferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2016-002660-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002660-13.